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The 173–195 segment corresponding to the helix 2 of the C-globular prion protein domain could be one of several “spots” of
intrinsicconformationalﬂexibility.Infact,itpossesseschameleonconformationalbehaviourandgathersseveraldisease-associated
pointmutations.Wehaveperformedspectroscopicstudiesonthewild-typefragment173–195andonitsD178Nmutantdissolved
in triﬂuoroethanol to mimic the in vivo system, both in the presence and in the absence of metal cations. NMR data showed that
the structure of the D178N mutant is characterized by two short helices separated by a kink, whereas the wild-type peptide is fully
helical. Both peptides retained these structural organizations, as monitored by CD, in the presence of metal cations. NMR spectra
were however not in favour of the formation of deﬁnite ion-peptide complexes. This agrees with previous evidence that other
regions of the prion protein are likely the natural target of metal cation binding.
Copyright © 2007 Luisa Ronga et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
The cellular prion protein is a synaptic glycoprotein ex-
pressed in the central nervous system, in lymphatic tis-
sue, and at neuromuscular junctions [1]. It is abundantly
spread in the brain of mammals, where it is attached to
the cell membrane by a glycosylphosphatidylinositol anchor
[2]. Although its physiological function is still largely un-
known, PrP protein is unequivocally associated to the onset
of a family of diseases named transmissible spongiform en-
cephalopathies (TSE) [3] by a mechanism involving the con-
version of the cellular form, PrPC, into an insoluble (scrapie)
variant, PrPSc, which is deemed to also retain an intrin-
sic infectivity [4]. These two PrP isomers substantially dif-
fer in their secondary structures [5–7]. Indeed, PrPC is pre-
dominantly α-helical with little β-sheet contribution [8, 9],
whereas PrPSc possesses a considerably higher β-sheet con-
tent, which suggests that isomerization is driven by a major
misfolding event leading to more extensive β-sheet confor-
mation.
According to this model, prion diseases are caused by
a rearrangement of the cellular form into proteinase-K-
resistant amyloidogenic, β-sheet-containing and potentially
infective structural variants [10–12] .T h er o l ep l a y e db ys u c h
variants in amyloid ﬁbril formation and consequently in
prion aetiopathogenesis is not deﬁnitely elucidated, nor has
themolecularlinkbetweenﬁbrilsanddiseaseyetbeenclearly
established. Several experimental observations suggest that
the interaction of PrP with membrane surface lipids [13, 14]
or with a yet unknown protein X [15, 16] might play a piv-
otal role in the protein early transformation and confor-
mational variability propagation. However, hypotheses cur-
rently under investigation clash with vagueness of informa-
tion about PrPSc structure. It has been also proposed that the
amyloid-forming tendency in prions, as well as in other ﬁb-
rillogenic proteins, could depend on the number of water ex-
posedbackboneH-bonds[17–19]andthattightlybackbone-
bound water molecules are of fundamental importance in
local protein stability and folding. In fact, some protein re-
gions exhibit an H-bond network poorly shielded from and2 Bioinorganic Chemistry and Applications
more vulnerable to bulk water attack, thus being more prone
to rearrangement. Such regions include speciﬁcally the helix
1, the C-terminal segment of the helix 2, the loop between
helix 2 and helix 3 and some residues within the helix 3,
which belong to the C-terminal globular domain. This do-
main has been implicated in the rearrangement mechanism
and in the formation of toxic ﬁbrils [20–25]. It has indeed
been shown that ablation of any of the prion helices leads to
protein variants unable to convert into PrPSc, while contex-
tual removal of an N-terminal portion (residues 23–89) and
of helix 1 (residues 144–157) produces highly infective pri-
ons [26, 27].
Particularly fascinating is the notion that the protein
possesses one or several “spots” of intrinsic conformational
weakness, which may lead the whole secondary and ter-
tiary structure to succumb in favour of more stable, but
aggregation-prone conformations, depending on pH, redox
condition, or glycosylation [21, 28]. The C-terminal side of
helix 2 is decidedly suspected to be one of such spots and,
in this regard, has recently gained the attention of several in-
vestigations [25, 29–33]. From these studies, it emerges that
the synthetic fragment corresponding to helix 2 is able to
adopt either α-helix or β-sheet conformation, and that such
a behaviour is likely under the control of the highly con-
served threonine-rich stretch 188–195. Furthermore, the he-
lix 2 fragment, also depending on the glycosylation state and
the presence of metals [20–22], can be toxic to neuronal cells
and strongly ﬁbrillogenic, adding a further clue to the work-
ing hypothesis that it is involved in the protein aggregation
process and in the toxicity associated to the scrapie variant.
Most recently, on the basis of H/D exchange data, Lu and
coworkers [34] have mapped the H-bonded β-sheet core of
PrP amyloid to the C-terminal region (starting at residue
≈ 169) that in the native structure of PrP monomer corre-
sponds to α-helix 2, a major part of α-helix 3, and the loop
betweenthesetwohelices.Asamatteroffact,severaldisease-
causing point mutations are also gathered on this region,
notably the D178N, V180I, T183A, H187R, T188R, T188K,
T188A, which are presumed to induce further protein desta-
bilization [31, 35–37] and to contribute to protein transfor-
mation.
The intriguing structural properties of this protein do-
main, as well as the inﬂuence that a disease-associated muta-
tion canhave onits relative stability, promptedus toperform
comparative NMR and CD structural investigations on two
peptides, hPrP[173–195] and hPrP[173–195]D178N. These
are derived from the wild type and the Creutzfeldt-Jakob-
disease-associated mutant [37] full length helix 2, respec-
tively, and can be therefore considered as representative con-
tributors to the conformational landscape of this region. No-
tably, these peptide fragments exhibited random organiza-
tion in aqueous solution (Ronga et al., unpublished results).
This is likely to be ascribed to the absence of mutual interac-
tions with the other helical segments as well as of the inter-
helical disulphide bridge, whichcontribute to the integrity of
the whole C-terminal globular domain in PrPC.T oa v o i de x -
perimental ambiguity due to the fact that the parent segment
in the native protein assumes helical conformation, we have
mimicked native-like conditions using the α-inducer triﬂu-
oroethanol (TFE) to force both peptides to assume a con-
formation as close as possible to that observed in the cellu-
lar prion protein. Furthermore, we have also investigated the
peptide interaction with metal cations.
2. MATERIAL AND METHODS
2.1. Peptidesynthesisandcharacterization
The N- and C-blocked peptides, hPrP[173–195] and
hPrP[173–195]D178N, with sequences AcNNFVHDCVNI-
TIKQHTVTTTTKGNH2 and AcNNFVHNCVNITIKQHT-
VTTTTKGNH2, respectively, were synthesized by standard
ﬂuorenylmethoxycarbonyl chemistry protocol as previously
described [29].
2.2. Circulardichroism
Far UV CD spectra of both peptides were recorded at room
temperature on a Jasco J-810 spectropolarimeter, using 1cm
quartz cell containing 20μM peptide dissolved in TFE to
mimic the α-helical structure of the parent segment in the
native protein. Spectra were also collected after addition of
increasing amounts of metal cations [Zn(II) and Cu(II)] up
t oa10:1metal/peptidemolarratio .I nan ycase,ﬁnalspectra
were obtained averaging three scans, subtracting the blank,
and converting the signal to mean residue ellipticity in units
of deg·cm2·dmol−1·res−1. Other experimental settings were
20nm/min scan speed, 2.0nm band width, 0.2nm resolu-
tion, 50mdeg sensitivity and 4seconds response.
2.3. NMRspectroscopy
All samples were prepared by dissolving the peptide under
investigation in TFEd2-OH (99%). NMR spectra were ac-
quired at 300K on a 600MHz Bruker Avance spectrom-
eter equipped with a cryoprobe. Natural abundance 1H-
15NH S Q Ca n d1H-13CH S Q C[ 38], TOCSY [39], NOESY,
[40] and double quantum ﬁltered COSY [41]s p e c t r aw e r e
used for resonance assignments. The H2O solvent reso-
nance was suppressed using the WATERGATE pulse se-
quence [42]. NOESY mixing times were set at 200, 300, and
400milliseconds to follow the NOE buildup rates. TOCSY
experiments were recorded with mixing times of 30 and
70milliseconds. Data were typically apodised with a Gaus-
sian window function and zero-ﬁlled to 1K in f1 prior to
Fourier transform. NMRPipe [43] and NMRView [44]p r o -
grams were used for data processing and spectral analysis,
respectively.Spinsystemidentiﬁcationandassignmentofin-
dividual resonances were carried out by using a combination
of TOCSY and DQF-COSY spectra. The TOCSY spectra of
all peptides showed well resolved resonances for almost all
residues, and sequence speciﬁc assignment was obtained by
the combined use of TOCSY and NOESY experiments, ac-
cording to the standard procedure [45]. One-dimensional
NMR spectra were also collected after the addition of small
aliquots of a 0.5M ZnCl2 aqueous stock solution to the pep-
tide solution.Luisa Ronga et al. 3
2.4. Structurecalculations
NOESY spectra at 300milliseconds mixing time were used
for the integration of NOE cross-peaks. Peak integrals were
evaluated by NMRView, transferred to the program pack-
age DYANA 1.0.6 [46], and converted to upper distance
limits by using the CALIBA [47]m o d u l eo fD Y A N A .D i s -
tance constraints were then worked out by the GRID-
SEARCH module to generate a set of allowed dihedral an-
gles. Structure calculation was carried out with the macro
ANNEAL module by torsion angle dynamics. Eighty struc-
tures were calculated by TSSA, starting with a total of
10000 MD steps and a default value of maximum temper-
ature. The thirty best structures in terms of target func-
tions were considered. A total of 193 and 150 distance re-
straints were used for structure calculation of hPrP[173–
195] and hPrP[173–195]D178N, respectively. These re-
straints, derived from interresidue, sequential, and medium
range NOEs, were introduced in SA torsion space calcula-
tion performed by DYANA package. The best thirty struc-
tures in terms of root mean square deviation (RMSD)
were selected from 80 structures sampled in TSSA calcula-
tions.
3. RESULTS
3.1. hPrP[173–195]
As shown in Figure 1, the far UV CD spectrum of hPrP[173–
195] in TFE solution shows features typical of α-helical con-
formation. The small spectral alterations that can be no-
t i c e do nm e t a lt i t r a t i o na r el i k e l yc a u s e db ym o d i ﬁ c a t i o n
of the dielectric properties of the solvent subsequent to
salt addition and do not suggest any speciﬁc binding in-
teraction between the peptide and the metal cation. The
bar diagram of diagnostic NOE eﬀects, as derived from the
NOESY spectrum in TFE at 300milliseconds mixing time,
is reported in Figure 2. Any ambiguity caused by the sig-
nals of the four consecutive Thr residues was overcome by
NOESY and 1H15N-HSQC experiments. 3JNH-CH coupling
constants assumed the very small values typical of α-helix.
Weak dαN(i,i+3) medium range, strong dNN(i,i+1) sequential as
well as strong dαβ(i,i+3) medium range eﬀects for almost all
residues are consistent with α-helical conformation. Table 1
s u m m a r i z e st o r s i o na n g l ev a l u e sa n dr e s p e c t i v eo r d e rp a -
rameters resulting from DYANA calculations. The 175–193
bundle of the best thirty DYANA structures, as obtained
by best ﬁtting of the backbone (RMSD = 1.13 ± 0.50 ˚ A),
is also drawn in Figure 2. Figure 3 depicts the amidic zone
of the 1D spectra after Zn(II) addition. The addition of
just one metal ion aliquot was suﬃcient to cause alter-
ation of the imidazolic proton resonances. Concentration-
dependent peptide aggregation on further metal addition
caused progressive broadening of all resonances, even caus-
ing them to disappear. Overall, this suggests nonspeciﬁc
metal-peptide interaction, a conclusion that is supported
by the unchanged shape of CD spectra, where aggrega-
tion did not occur because of the lower peptide concentra-
tion.
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Figure 1: Far UV CD spectra of hPrP[173–195] dissolved in TFE
before and after addition of ZnCl2 solution. A similar spectral be-
haviour was observed after titration with CuCl2 solution (spectra
not shown).
3.2. hPrP[173–195]D178N
The lower intensity of the far UV CD spectrum of hPrP[173–
195]D178N, run in the same condition as that of hPrP[173–
195] (Figure 4),suggests that the mutant peptide is less heli-
cal as compared to the wild type peptide. However, the con-
clusion that no speciﬁc binding interaction with the metal
cation can be detected still holds for this peptide. In TOCSY
experiments, it has been found that the replacement of
Asp178withAsndoesnotsubstantiallyaﬀectchemicalshifts.
Only 0.2ppm protonic chemical shifts of HN and the CHβ
of Asn178 as compared to Asp178 were recorded by super-
imposition of the two TOCSY experiments. Careful analy-
sis of the NOESY spectrum highlighted that eﬀects typical of
secondary structure are essentially located in the N-terminal
region, even though the intensity of the dNN(i,i+1) ones was
reduced. The dαN(i,i+1) between the H-Cα and the HN-proton
of Gln186 and His187, respectively, suggested the local pres-
ence of an extended conformation in the modiﬁed peptide,
strongly perturbing the central core of the wild type helix
motif. This is in good agreement with the lower helical con-
tent of the CD spectrum of hPrP[173–195]D178N. Figure 5
shows all diagnostic NOE eﬀects as well as the superimpo-
sition of the best thirty structures obtained by DYANA cal-
culations (region 175–193). However, the value of the back-
bone RMSD of 2.07 ± 0.61 ˚ A suggests the presence of sev-
eral quite similar conformations. Torsion angle values and
respective order parameters, as obtained by DYANA calcula-
tions (Table 2), validated the presence of a kink centred on
Lys185 and Gln186. The amidic zone of 1D NMR spectra of
hPrP[173–195]D178N in the presence of various amounts of
Zn(II) is reported in Figure 6. The protonic resonances of
the His side chains exhibit the same behaviour as that ob-
servedforthewildtypepeptidefragment,buttheprogressive4 Bioinorganic Chemistry and Applications
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Figure 2:NOEeﬀectsandDYANAbackboneﬁttingofhPrP[173–195].ConnectivitieswerederivedfromNOESYspectraat300milliseconds
mixing time. Backbone NOE connectivities are indicated by horizontal lines between residues, with thickness indicating their relative mag-
nitude.Theﬁrstthreelinesbelowtheaminoacidsequencerepresenttorsionanglerestraintsforthebackbonetorsionangles φ andψ,andfor
theside-chaintorsionangleχ1.F orφ andψ,a symbolenclosessecondary-structure-typeconformation;asymbolindicatescompatibility
with an ideal α-helix; and a • symbol marks a restraint that excludes the torsion angle values of these regular secondary structure elements.
Filled squares of diﬀerent sizes depict torsion angle restraints for χ1, depending on the number of allowed staggered rotamer positions. The
bundle of the region 175–193 of the best 30 DYANA structures was obtained by best ﬁtting of the backbone (RMSD = 1.13 ±0.50 ˚ A).
Table 1: Torsional angles and order parameters for hPrP[173–195].
Residue φφ S ψψ Sχ 1 χ1S
Asn173 −89.9 ±4.6 0.997 −54.4 ±3.2 0.999 −122.6 ±4.2 0.997
Asn174 −59.0 ±9.9 0.986 −57.2 ±7.1 0.993 −132.6 ±86.5 0.253
Phe175 −46.0 ±8.3 0.990 −40.7 ±13.0 0.976 130.1 ±53.8 0.626
Val176 −69.2 ±12.9 0.977 −52.4 ±6.0 0.995 150.2 ±10.1 0.986
His177 −46.7 ±1.2 1.000 −32.5 ±4.8 0.997 −156.9 ±9.4 0.987
Asp178 −75.2 ±2.7 0.999 −41.6 ±3.8 0.998 −149.7 ±0.4 1.000
Cys179 −64.7 ±1.0 1.000 −42.8 ±0.5 1.000 −132.5 ±0.3 1.000
Val180 −47.8 ±0.6 1.000 −74.0 ±0.6 1.000 142.5 ±0.7 1.000
Asn181 −49.6 ±0.3 1.000 −45.9 ±0.7 1.000 −145.8 ±0.6 1.000
Ile182 −52.6 ±0.8 1.000 −31.0 ±1.6 1.000 −74.8 ±2.8 0.999
Thr183 −84.7 ±3.2 0.999 −38.6 ±1.4 1.000 −138.2 ±1.0 1.000
Ile184 −73.3 ±1.7 1.000 −16.2 ±4.3 0.997 −142.9 ±3.7 0.998
Lys185 −38.0 ±1.1 1.000 −63.6 ±0.7 1.000 −159.5 ±0.5 1.000
Gln186 −59.6 ±9.0 0.988 −46.0 ±7.8 0.991 −101.4 ±3.9 0.998
His187 −38.9 ±0.9 1.000 −70.2 ±7.5 0.992 178.7 ±38.6 0.796
Thr188 −47.8 ±5.9 0.995 −34.5 ±2.0 0.999 −99.6 ±15.2 0.968
Val189 −95.1 ±2.9 0.999 34.2 ±11.6 0.980 −169.9 ±9.9 0.986
Thr190 −94.6 ±31.9 0.856 −69.3 ±15.9 0.963 −48.8 ±71.3 0.349
Thr191 −78.9 ±46.0 0.724 −15.4 ±28.1 0.889 −39.8 ±75.1 0.322
Thr192 −75.2 ±17.2 0.957 −55.5 ±10.4 0.984 −95.3 ±37.0 0.818
Thr193 −78.4 ±16.2 0.962 146.4 ±92.1 0.380 −76.6 ±92.5 0.139
Lys194 45.0 ±18.0 0.958 94.8 ±65.5 0.662 −110.9 ±60.5 0.713
Gly195 −16.9 ±71.7 0.513 49.9 ±78.6 0.336 — —Luisa Ronga et al. 5
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Figure 3: 1D NMR spectra of hPrP[173–195] dissolved in TFE-d2
beforeandafteradditionofZnCl2 solution.Labels1,2,4,and10in-
dicate the total volume (μl) of 0.5 M ZnCl2 solution added to 500μl
of 0.6mM peptide solution, corresponding to Zn(II)/peptide molar
ratios of 1.7, 3.3, 6.7, and 16.7, respectively. Imidazolic proton reso-
nances of His residues in metal absence are marked by an asterisk.
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Figure 4: Far UV CD spectra of hPrP[173–195]D178N dissolved in
TFE before and after addition of ZnCl2 solution. A similar spectral
behaviour was observed after titration with CuCl2 solution (spectra
not shown).
broadening of side-chain resonances is less relevant. As al-
ready observed for hPrP[173–195], these data are not sug-
gestive of well-deﬁned ion-peptide complex formation.
4. DISCUSSION
In this work, we report comparative CD and NMR data
on the synthetic peptides hPrP[173–195] and hPrP[173–
195]D178N, which are related to the α2-helical region of
the prion protein and represent the wild type sequence and
its D178N mutant, respectively, both in the absence and in
the presence of metal cations. As can be judged from far
UV CD spectra, the two negative bands at 222 and 208nm,
and a positive band at 192nm indicate that both peptides
exhibit α-helical arrangement. However, the lower intensity
that characterizes the spectrum of the mutant peptide sug-
gests some rearrangement as compared to the single helical
structure exhibited by the wild type peptide. In fact, there
is NMR evidence that the conformation of the wild type
peptide is signiﬁcantly aﬀected by replacing the negatively
charged Asp178 with a neutral Asn residue. In the mutant
peptide, increased conformational freedom characterizes all
residues downstream Gln188, which ultimately causes un-
winding and bending of the wild type fully helical struc-
ture.Asaconsequence,structuralrearrangementleads tothe
formation of two short helices separated by a kink centred
on Lys185 and Gln186. In this bent structure, His177 and
His187 approach to each other as compared to the parent
helical peptide, forming two major conformational families,
characterized by proximal and distal imidazole rings, respec-
tively. Moreover, the network of stabilizing H-bonds mainly
involves the interaction between Asn174 and Thr188 (head-
to-tail type) and between Asn181 and His187 or Gln186
(core type) (Figure 7). In conclusion, we argue that the neg-
ative charge of Asp178 plays a key role in forcing the entire
173–195 fragment to assume a full helical conformation.
For both peptides, addition of increasing metal cation
aliquots did not perturb NMR spectra in any speciﬁc way.
The chemical shifts of all resonances did not vary, as it could
beexpectedincaseofmetal-peptidecomplexformation,and
the overall eﬀect was a progressive generalized broadening of
all relevant resonances. In fact, addition of higher and higher
metal aliquots caused irreversible aggregation, which always
lies in wait when the peptide concentration is very high, pos-
sibly owing to ionic strength increase and/or to water addi-
tion on metal cation titration. However, that the interaction
of the metal with the peptide backbone is nonspeciﬁc was
conﬁrmed by the unaltered appearance of CD spectra after
metal addition, where aggregation did not occur thanks to
the lower peptide concentration. These were performed in
neat TFE to conform to the conditions of NMR experiments,
but further experiments in mixed water/TFE solvent sug-
gested that water-induced eﬀects largely dominate structural
rearrangements, rendering metal-induced modiﬁcations, if
any, hard to discriminate.
Among studies that have been carried out on metal in-
teraction with peptides derived from the PrP C-terminus,
it is worth mentioning that recently Brown and coauthors
[22]have characterizedthe formation ofdiﬀerent Cu2+ com-
plexes in blocked and free C- and N-termini analogues of
the peptide fragment 180–193 (VNITKQHTVTTTT), which
almost entirely encompasses the PrPC’s α2-helix. They sug-
gested that the binding site of copper(II) in the structured
region of the protein is located on the His187 residue, and
that the anchoring imidazole residue drives the metal co-
ordination environment towards a common binding mo-
tif in diﬀerent regions of the prion protein. Other studies
[48]showedthatthePrP178–193peptidehasbothstructural6 Bioinorganic Chemistry and Applications
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Figure 5: NOE eﬀects and DYANA backbone ﬁtting of hPrP[173–195]D178N. Connectivities were derived from NOESY spectra at
300milliseconds mixing time. Symbols used for connectivities are the same as reported in Figure 2. The bundle of the region 175–193
of the best 30 DYANA structures was obtained by best ﬁtting of the backbone (RMSD = 2.07 ± 0.61 ˚ A).
Table 2: Torsional angles and order parameters for hPrP[173–195]D178N.
Residue φφ S ψψ S χ1 χ1S
Asn173 —— −176.7 ±57.0 0.759 −57.9 ±52.5 0.673
Asn174 −0.4 ±73.3 0.389 −50.5 ±10.5 0.984 169.7 ±83.2 0.294
Phe175 −65.1 ±12.0 0.979 −65.8 ±14.5 0.969 −114.0 ±31.8 0.863
Val176 −61.1 ±4.8 0.997 −35.1 ±15.0 0.967 171.2 ±7.9 0.991
His177 −62.7 ±8.9 0.988 −13.9 ±7.2 0.992 −65.7 ±109.8 0.187
Asn178 −58.6 ±12.6 0.977 −38.1 ±17.1 0.957 176.4 ±11.8 0.980
Cys179 −75.8 ±42.6 0.750 −18.4 ±20.3 0.940 −170.6 ±18.5 0.950
Val180 −102.6 ±16.5 0.960 −36.5 ±8.1 0.990 168.1 ±19.7 0.945
Asn181 −57.8 ±5.7 0.995 −31.0 ±12.5 0.977 −168.0 ±12.3 0.978
Ile182 −60.2 ±16.7 0.959 −29.2 ±19.3 0.947 −71.1 ±9.6 0.986
Thr183 −92.2 ±25.2 0.910 −34.6 ±16.0 0.963 −76.3 ±12.5 0.977
Ile184 −82.7 ±20.7 0.938 −44.3 ±10.5 0.984 −72.1 ±7.2 0.992
Lys185 79.7 ±12.8 0.976 2.6 ±42.2 0.752 −137.8 ±24.5 0.923
Gln186 −142.7 ±9.7 0.986 −7.6 ±77.5 0.273 −19.5 ±86.4 0.208
His187 −55.6 ±50.8 0.687 −111.7 ±45.2 0.754 −157.1 ±36.1 0.820
Thr188 −23.4 ±47.8 0.736 −39.8 ±9.1 0.988 −87.7 ±36.4 0.816
Val189 −54.5 ±14.3 0.970 −44.6 ±13.1 0.975 163.8 ±9.9 0.986
Thr190 −48.2 ±10.2 0.985 −47.6 ±13.3 0.974 −178.0 ±70.3 0.516
Thr191 −71.1 ±78.5 0.434 −65.7 ±13.7 0.973 −38.1 ±48.4 0.699
Thr192 −163.3 ±70.3 0.455 −51.9 ±24.0 0.918 −63.3 ±40.6 0.809
Thr193 −103.8 ±85.0 0.309 −140.6 ±65.3 0.468 −128.7 ±42.3 0.751
Lys194 89.9 ±78.6 0.332 129.4 ±85.7 0.411 −135.6 ±55.0 0.682
Gly195 160.8 ±70.8 0.444 — — — —
and bioactive properties in common with the amyloido-
genic Alzheimer’s disease Aβ(25–35) peptide and that the
second putative helical region of PrP could be involved in
modulation of Cu (II)-mediated toxicity in neurons dur-
ing prion disease. However, our results suggest that the
interaction of metal cations with peptide fragments de-
rived from the C-terminal globular domain could be af-
fected by experimental ambiguity caused by the fact that
the structural organization of these peptides is diﬀerent
from that assumed in PrPC.W eb e l i e v et h a ti ti sc r u c i a l
to take this aspect into account when designing experi-
ments aimed at investigating peptide-metal cation interac-
tion.
It is known that the lack of mutual interactions has dra-
matic eﬀects on the integrity of the whole helical domain of
theprionprotein,andthestabilityofonesinglehelicalregion
stronglysuﬀersfromablationoftheotherhelicalsegmentsas
well as of the disulphide bridge. However, native-like condi-
tions can be to some extent restored choosing a medium that
may help extract useful information using the peptide frag-
ment approach. Thus, we have used TFE as the most suitable
environment to investigate structural similarities between
the wild type and the D178N mutant fragment correspond-
ing to the helix 2. Our experiments conﬁrm that it is reason-
able to suspect the involvement of this region in the PrPC-
PrPSc conversion, as emerging evidence points out [34, 49]Luisa Ronga et al. 7
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Figure 6: 1D NMR spectra of hPrP[173–195]D178N dissolved in
TFE-d2 before and after addition of ZnCl2 s o l u t i o n .L a b e l s1 ,2 ,
4, and 16 indicate the total volume (μl) of 0.5 M ZnCl2 solu-
tion added to 500μl of 1.0mM peptide solution, corresponding to
Zn(II)/peptide molar ratios of 1.0, 2.0, 4.0, and 16.0, respectively.
Imidazolic proton resonances of His residues in metal absence are
marked by an asterisk.
Figure 7: Stereo view of the backbone structure of hPrP[173–
195]D178N. Clusters identify two major conformational families,
with proximal (top) and distal (bottom) histidine imidazolic rings.
and we ourselves have suggested elsewhere [29, 50, 51]. As a
proof of the structural ﬂexibility of this segment, which can
be also inferred from an analysis of PrP pathological variants
[52–54], the D178N CJD-associated variant, that is the most
important mutation occurring in CJD, is not even able to as-
sume a fully helical structure, like that found in PrPC,i na n
α-inducingenvironment.Thissupportstheviewthatthesin-
gle Asp178 residue is of foremost importance in maintaining
the structural properties of the PrP globular domain.
Furthermore, in the peptide fragment approach, it is un-
likelythataqueousbuﬀeristhemostsuitableenvironmentto
analyzemetalinteractionwithpeptidefragments,whosepar-
ent segments in the native protein experience diﬀerent envi-
ronmental conditions. Concerning the role played by metal
cations in the PrPC-PrPSc isomerisation, we have shown that
the use of the α-helix-inducer TFE to force peptides into a
conformation close to the helical one that has been found
in PrPC may lead to conclusions diﬀerent from those that
can be obtained studying metal cation interaction with pep-
tides in buﬀer solution. To embed our results in the body of
data on PrP structure and function, it is worth considering
that the three-dimensional architecture of PrPC consists of
an unstructured leading tail encompassing residues 23–125
and a C-terminus globular domain, in which residues 126–
231 are organized in three α-helices and a two-stranded β-
sheet [55, 56]. Although it is currently believed that the ma-
jor structural modiﬁcations involved in PrP protein misfold-
ing are located in the unstructured N-terminal region, the
present work seems to provide further support to evidence
accumulatedintheliteraturethatthetwopriondomainsplay
ad i ﬀerent role in the prion conversion, stressing that the N-
terminal domain is likely the natural target of metal binding;
see [57, 58] and references cited therein.
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